Robert Di Scipio, CEO of Skyland Analytics, and Steve Goodman, head of drug manufacturing at bluebird bio, gave a presentation together at Phacilitate Leaders World Stem Cell Summit 2019 held January 22-25th. The presentation addressed the complex challenges that face cell and gene therapy development and manufacturing and their solutions to those issues.
As a result of the high level of interest in the topic, both companies were chosen by BioProcess International (BPI) to co-author the following article: Cell and Gene Therapy Data Management: Solutions to Address Complex Challenges.
Skyland and bluebird are collaborating to ensure that bluebird has a CFR Part 11 compliant data management system that supports data transparency and analytics throughout its supply chain.